Rieder MJ - Search Results

1

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.

Cooper GM, Johnson JA, Langaee TY, Feng H, Stanaway IB, Schwarz UI, Ritchie MD, Stein CM, Roden DM, Smith JD, Veenstra DL, Rettie AE, Rieder MJ. Cooper GM, et al. Among authors: rieder mj. Blood. 2008 Aug 15;112(4):1022-7. doi: 10.1182/blood-2008-01-134247. Epub 2008 Jun 5. Blood. 2008. PMID: 18535201 Free PMC article.

2

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Rieder MJ, et al. N Engl J Med. 2005 Jun 2;352(22):2285-93. doi: 10.1056/NEJMoa044503. N Engl J Med. 2005. PMID: 15930419 Free article.

3

In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose.

Tai G, Farin F, Rieder MJ, Dreisbach AW, Veenstra DL, Verlinde CL, Rettie AE. Tai G, et al. Among authors: rieder mj. Pharmacogenet Genomics. 2005 Jul;15(7):475-81. doi: 10.1097/01.fpc.0000162005.80857.98. Pharmacogenet Genomics. 2005. PMID: 15970795

4

The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies.

Rieder MJ, Livingston RJ, Stanaway IB, Nickerson DA. Rieder MJ, et al. Drug Metab Rev. 2008;40(2):241-61. doi: 10.1080/03602530801952880. Drug Metab Rev. 2008. PMID: 18464045 Review.

5

An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.

Meckley LM, Wittkowsky AK, Rieder MJ, Rettie AE, Veenstra DL. Meckley LM, et al. Among authors: rieder mj. Thromb Haemost. 2008 Aug;100(2):229-39. Thromb Haemost. 2008. PMID: 18690342

6

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.

McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. McDonald MG, et al. Among authors: rieder mj. Mol Pharmacol. 2009 Jun;75(6):1337-46. doi: 10.1124/mol.109.054833. Epub 2009 Mar 18. Mol Pharmacol. 2009. PMID: 19297519 Free PMC article.

7

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.

Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ; International Warfarin Pharmacogenetics Consortium. Limdi NA, et al. Blood. 2010 May 6;115(18):3827-34. doi: 10.1182/blood-2009-12-255992. Epub 2010 Mar 4. Blood. 2010. PMID: 20203262 Free PMC article.

8

CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes.

Veenstra DL, Blough DK, Higashi MK, Farin FM, Srinouanprachan S, Rieder MJ, Rettie AE. Veenstra DL, et al. Among authors: rieder mj. Clin Pharmacol Ther. 2005 May;77(5):353-64. doi: 10.1016/j.clpt.2005.01.019. Clin Pharmacol Ther. 2005. PMID: 15900281

9

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population.

Veenstra DL, You JH, Rieder MJ, Farin FM, Wilkerson HW, Blough DK, Cheng G, Rettie AE. Veenstra DL, et al. Among authors: rieder mj. Pharmacogenet Genomics. 2005 Oct;15(10):687-91. doi: 10.1097/01.fpc.0000174789.77614.68. Pharmacogenet Genomics. 2005. PMID: 16141794

10

Direct detection of null alleles in SNP genotyping data.

Carlson CS, Smith JD, Stanaway IB, Rieder MJ, Nickerson DA. Carlson CS, et al. Among authors: rieder mj. Hum Mol Genet. 2006 Jun 15;15(12):1931-7. doi: 10.1093/hmg/ddl115. Epub 2006 Apr 27. Hum Mol Genet. 2006. PMID: 16644863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page